All News Jenscare Scientific Co., Ltd.

Equities

9877

CNE100005KC9

Market Closed - Hong Kong S.E. Other stock markets 04:08:09 2024-05-16 am EDT			5-day change	1st Jan Change
4.62 ^HKD	-2.33%		-2.74%	-79.19%

Apr. 25	Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%	MT
Mar. 27	Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%	Apr. 25	MT
Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Jenscare Scientific's Mitral Valve Device Completes Enrollment for Confirmatory Clinical Trials	Mar. 24	MT
Jenscare Scientific Co., Ltd. Announces Completion of the Enrollment of JensClip for Confirmatory Clinical Trial and One-Month Follow-Up	Mar. 24	CI
Jenscare Scientific Secures HKEX Nod for H Share Circulation	Mar. 19	MT
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation in Brazil	Feb. 28	CI
Jenscare Scientific’s CEO, CFO Boost Stake in Firm	Jan. 26	MT
Jenscare Scientific Unit Concludes 1st Clinical Implantation of PFO Occluder System	Jan. 03	MT
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation of Omniseal	Jan. 02	CI
Jenscare Scientific to Buy Back Shares	Dec. 29	MT
Jenscare Scientific Shareholders Approve of Sale of 22.48% Interest in Congenital Heart Disease Device Maker	Dec. 22	MT
Jenscare Scientific to Divest 22.5% Stake in Medical Device Maker	Nov. 29	MT
Jenscare Releases Results of Confirmatory Trial for Tricuspid Valve Replacement in London Meet	Nov. 27	MT
Jenscare Scientific Co., Ltd. Announces One-Year Results of the Confirmatory Clinical Trial of the LuX-Valve Transcatheter Tricuspid Valve Replacement System	Nov. 27	CI
Jenscare Scientific Enrolls First Patient for Atrial Appendage Occluder System Trial	Nov. 13	MT
Jenscare Presents Results of Tricuspid Valve Replacement System at US Conference	23-10-30	MT
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Travel II Results Released At the 2023 TCT in the U.S	23-10-30	CI
Jenscare Shares Surge 16% After China Grants Priority Approval for Aortic Heart Valve System	23-10-29	MT
Jenscare Scientific Co., Ltd. Announces Registration Application of Ken-Valve, the Transcatheter Prosthetic Aortic Heart Valve System Successfully Enters the Priority Approval Process	23-10-29	CI
Jenscare Scientific Applies Valve Replacement System Under Fee-for-Service Scheme in Asia-Pacific; Shares Tumble 9%	23-10-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Jenscare Scientific Co., Ltd.

Equities

9877

CNE100005KC9

All News

Filters